Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
178.49
+3.03 (1.73%)
Feb 27, 2026, 4:00 PM EST - Market closed

CRL Revenue

In the year 2025, Charles River Laboratories International had annual revenue of $4.02B, down -0.85%. Charles River Laboratories International had revenue of $994.23M in the quarter ending December 27, 2025, a decrease of -0.83%.

Revenue (ttm)
$4.02B
Revenue Growth
-0.85%
P/S Ratio
2.19
Revenue / Employee
$203,826
Employees
19,700
Market Cap
8.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 27, 20254.02B-34.61M-0.85%
Dec 28, 20244.05B-79.42M-1.92%
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 2020 Pro Pro Pro
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Quest Diagnostics 11.04B
ICON Public Limited Company 8.10B
Illumina 4.34B
Exact Sciences 3.25B
Revvity 2.86B
Medpace Holdings 2.53B
Qiagen 2.09B
RadNet 1.97B
Revenue Rankings